CisplatinLeukemiaLeukemia, Myeloid, AcuteLeukemia, Lymphocytic, Chronic, B-CellLeukemia, ExperimentalLeukemia, LymphoidAntineoplastic AgentsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHL-60 CellsLeukemia L1210Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Monocytic, AcuteTumor Cells, CulturedAntineoplastic Combined Chemotherapy ProtocolsLeukemia Virus, MurineGene Expression Regulation, LeukemicLeukemia, T-CellApoptosisK562 CellsDrug Resistance, NeoplasmLeukemia, B-CellLeukemia P388Cell Line, TumorLeukemia, MyeloidLeukemia, Hairy CellMoloney murine leukemia virusCytarabinePlatinumFusion Proteins, bcr-ablDrug Screening Assays, AntitumorDrug SynergismEtoposideLeukemia Virus, BovineLeukemia Virus, FelineLeukemia-Lymphoma, Adult T-CellCell SurvivalCell LineMyeloid-Lymphoid Leukemia ProteinPrecursor B-Cell Lymphoblastic Leukemia-LymphomaCell DifferentiationLeukemia, Promyelocytic, AcuteLeukemia, Radiation-InducedLeukemia, Basophilic, AcuteNeoplasm ProteinsLeukemia, Megakaryoblastic, AcuteFriend murine leukemia virusDrug Administration ScheduleDaunorubicinDose-Response Relationship, DrugTreatment OutcomeCombined Modality TherapyRemission InductionLeukemia, Biphenotypic, AcuteTretinoinBone MarrowCell DivisionAcute DiseaseDoxorubicinU937 CellsDNA, NeoplasmSurvival AnalysisLung NeoplasmsVinblastineProto-Oncogene Proteins c-bcl-2Flow CytometryRNA, MessengerDeoxycytidineBase SequenceOvarian NeoplasmsCell CycleDrug ResistanceDisease-Free SurvivalAntineoplastic Agents, PhytogenicDNA AdductsMolecular Sequence DataAKR murine leukemia virusFluorouracilMyeloid Cell Leukemia Sequence 1 ProteinPaclitaxelCell ProliferationKaryotypingSurvival RateMethotrexateOxidesAntimetabolites, AntineoplasticArsenicalsCaspasesTime FactorsProto-Oncogene ProteinsSignal TransductionLeukemia, Myeloid, Chronic-PhaseJurkat CellsDNA-Binding ProteinsGene Expression Regulation, Neoplasticfms-Like Tyrosine Kinase 3RNA, NeoplasmNeoplastic Stem CellsAntibiotics, AntineoplasticVincristinePrecursor T-Cell Lymphoblastic Leukemia-Lymphoma